StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
0NCV.IL$23.18-2.71%
Fair $23.18+0.0%

0NCV.IL

Lenzing Aktiengesellschaft

Basic Materials / ChemicalsIOB

$23.18

-0.65 (-2.71%)

Fairly Valued+0.0%Fair Value $23.18Fund rank 20/100 · Data gapFallback financials|
SA 24/D
F-Score: 3/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 14%

FCF escenarios

weak_data · normalized FCF $241.3M · quality 25.7/100

Data gap 20/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 9/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

24/100

D

Piotroski

3/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists. ROE is -17.6%, below the 5% threshold
Thesis & Journal · 0NCV.ILLocal privado en este navegador · Lenzing Aktiengesellschaft
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$1.0B

P/E

N/A

•

EV/EBITDA

5.7x

↓

ROE

-17.6%

↓

Gross Margin

13.0%

↓

Debt/Equity

1.71

↑
52-Week Range$23
$19$28

TradingView lightweight chart

0NCV.IL price, volumen y niveles de valoración

Último $24.70Periodo -45.6%
Fair value: $23.18

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+0.5%

FCF CAGR

—

FCF margin

10.7%

FCF / Net income

-1.62x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $2.60B · net income $-172.0M · FCF $278.7M

2022-FY → 2025-FY

Gross margin

13.0%-2.7% pts

Operating margin

1.1%+0.9% pts

Net margin

-6.6%-4.9% pts

FCF margin

10.7%+39.6% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$2.60B$2.60B$2.66B$2.52B$2.57B
Net Income$-172.0M$-172.0M$-127.9M$-620.7M$-44.3M
EBITDA$328.5M$328.5M$427.2M$-158.4M$250.7M
EPS-5.45-5.45-4.06-20.02-2.75
Gross Margin13.0%13.0%19.1%-3.0%15.7%
Operating Margin1.1%1.1%2.9%-18.3%0.2%
Net Margin-6.6%-6.6%-4.8%-24.6%-1.7%
Balance Sheet
Debt/Equity1.711.711.401.321.19
Current Ratio1.561.56———
Cash Flow
Free Cash Flow$278.7M$278.7M$241.3M$-107.5M$-742.1M
Returns
ROE-17.6%-17.6%-9.8%-43.1%-2.5%
Valuation
EV/EBITDA5.745.745.94—12.68
P/B0.920.920.880.780.89
Growth & Yield
Revenue Growth-2.3%-2.3%5.7%-1.7%—
EPS Growth-34.2%-34.2%79.7%-628.0%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -9.8%

Total return

-9.8%

Start / end P/E

n/dx → n/dx

EPS bridge

-4.06 → -5.45

Residual

-9.8%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-9.8%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.